Get the executive knowledge on Pharma Outsourcing: free podcast @ 2020Pharma.com

The podcast is an insightful analysis of pharma outsourcing and includes comments on attractive partners, service providers, keeping strength, maintaining core specialties and the future for the industry.
By: 2020PHARMA
 
May 17, 2011 - PRLog -- Industry experts go head to head in 20/20 Pharma’s ‘Working hand-in-hand for the future of Pharma Outsourcing’ podcast discussion. With the global pharma outsourcing market expected to grow to an estimated $83 billion in 2011 (as cited by various publications), this discussion covers all the critical issues facing pharma companies. The podcast is available to download free at:

http://www.2020pharma.com/podcast/working-hand-hand-future-pharma-outsourcing-0

The podcast is moderated by Ken Savin, Advisor to Special Projects in the Global External Research and Development and Due Diligence groups at Eli Lilly and Company. Ken is joined by four industry experts: Mark Roseman of Kendle, Steven Hutchins of Evotec, and Ronald Yarger and Ving Lee of Adesis to discuss the current trends in pharma outsourcing.

The podcast is an insightful analysis of pharma outsourcing and includes comments on:
-   Competitive pressures to becoming an attractive partner
-   Advantages to having an integrated or cross functional individual partner
-   Keeping strength and maintaining core specialties
-   How the role of service providers is developing
-   Finding employees who are able to step up and be those partners
-   Key factors in developing and maintaining successful relationships with partners
-   The future of the pharma industry

In the podcast Kendle’s Mark Roseman said: “Things are moving away from the single project by project outsourcing mindset and as things evolve it is becoming very clear that it is in everybody's best interests to be outsourcing on a bigger level.

“What we are seeing is that Pharma is outsourcing a greater percentage of their work and they are outsourcing to fewer and fewer partners, which makes a lot of sense because you can in fact build an efficiency as you go that route.”

20/20 Pharma director Farrah Tuttle said: “As always, Ken Savin has been a great asset for 20/20 Pharma and his experience in the industry provided excellent information for the Pharma Outsourcing roundtable discussion.”

For more information and topical pharmaceutical related podcasts visit www.2020pharma.com.

About 20/20 Pharma
20/20 Pharma is a product of IMI Publishing Ltd, dedicated to offering its clients and partners a unique opportunity to not only advertise the capabilities of their companies, but also showcase their technology or services through in-depth educational pieces and targeted online events.
Dedicated to being a trusted and authoritative resource within top pharmaceutical companies, as well as small, specialty and biotech businesses, 20/20 Pharma bridges the gap between the industry’s top issues and the solutions that top-tier vendors can provide.

Contact details
Pinar Gencturk
Managing Editor, 20/20 Pharma
+44 207 148 5152 | pgencturk@imipublishing.com

# # #

20/20 Pharma, published by IMI, is a magazine which presents insightful analysis of current events, developments, and trends in the pharmaceutical world.
End
Source:2020PHARMA
Email:***@imipublishing.com Email Verified
Zip:EC1R 3BU
Tags:Pharma, Outsourcing, Attractive partners, Service Providers, Pharmaceutical Company, Contract Services, Pharmaceutical
Industry:Pharmaceutical
Location:London City - London, Greater - England
Account Email Address Verified     Disclaimer     Report Abuse
20/20PHAMA News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share